Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 3Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1

Interventions

Specimen Handling 22Magnetic Resonance Spectroscopy 20Carboplatin 17Gemcitabine 15pembrolizumab 13Cisplatin 13Paclitaxel 12Injections 11Interviews as Topic 10fludarabine 9Radiotherapy 9Cyclophosphamide 9Oxaliplatin 8Dexamethasone 8Biopsy 8Bevacizumab 8toripalimab 7Nivolumab 7Irinotecan 7Fluorouracil 7Bortezomib 7X-Rays 6Radiosurgery 6Pemetrexed 6Leucovorin 6Capecitabine 6durvalumab 5cemiplimab 5anlotinib 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × sargramostim × 30 days × Clear all
NCT07169617 2026-06-03

Testing the SurVaxM Vaccine for Lung Cancer Prevention

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
80 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡